Premium
Elutia Inc (ELUT)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Kevin L. RakinIndependent Chairman & Lead Independent Director | -120,00k | 0,00 | Other Disposition | - | 398,54k | -23,14% |
| 2025-12-10 | Mr. Guido Julius NeelsIndependent Director | 6,25k | 0,00 | Derivative Exercise and Retained Stock | - | 125,00k | 5,26% |
| 2026-03-10 | Mr. Matthew B. FergusonCFO | -5,12k | 5,58k | Derivative Exercise and Sale | 1,09 | 472,07k | - |
| 2026-03-10 | Mr. Matthew B. FergusonCFO | 7,38k | 0,00 | Derivative Exercise and Retained Stock | - | 472,07k | 1,59% |
| 2026-03-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | -11,10k | 12,10k | Derivative Exercise and Sale | 1,09 | 409,41k | - |
| 2026-03-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 15,98k | 0,00 | Derivative Exercise and Retained Stock | - | 409,41k | 4,06% |
| 2026-03-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | 7,89k | 0,00 | Derivative Exercise and Retained Stock | - | 109,82k | 7,74% |
| 2026-03-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | -4,61k | 5,03k | Derivative Exercise and Sale | 1,09 | 109,82k | - |
| 2026-01-30 | Mr. Kevin L. RakinIndependent Chairman & Lead Independent Director | 70,00k | 74,20k | Achat | 1,06 | 518,54k | 15,61% |
| 2026-01-30 | Mr. Guido Julius NeelsIndependent Director | 20,00k | 20,80k | Achat | 1,04 | 118,75k | 20,25% |
| 2026-01-28 | Mr. Guido Julius NeelsIndependent Director | 30,00k | 31,80k | Achat | 1,06 | 98,75k | 43,64% |
| 2025-12-17 | Mr. Kevin L. RakinIndependent Chairman & Lead Independent Director | 50,00k | 26,00k | Achat | 0,52 | 448,54k | 12,55% |
| 2025-12-17 | Mr. Matthew B. FergusonCFO | 60,00k | 31,80k | Achat | 0,53 | 447,11k | 15,50% |
| 2025-12-17 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 3,00k | 1,53k | Achat | 0,51 | 379,20k | 0,80% |
| 2025-12-17 | Mr. David ColpmanIndependent Director | 12,50k | 6,38k | Achat | 0,51 | 31,10k | 67,21% |
| 2025-12-17 | Ms. Brigid Ann MakesIndependent Director | 25,00k | 13,00k | Achat | 0,52 | 27,00k | 1 250,00% |
| 2025-12-11 | HighCape Partners Management, L.P.Société | -4,51M | 0,00 | Other Disposition | - | 4,71M | -48,91% |
| 2025-12-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 17,42k | 0,00 | Derivative Exercise and Retained Stock | - | 376,20k | 4,85% |
| 2025-12-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | -9,66k | 6,76k | Derivative Exercise and Sale | 0,70 | 376,20k | - |
| 2025-12-10 | Mr. Matthew B. FergusonCFO | 8,04k | 0,00 | Derivative Exercise and Retained Stock | - | 387,11k | 2,12% |
| 2025-12-10 | Mr. Matthew B. FergusonCFO | -4,46k | 3,12k | Derivative Exercise and Sale | 0,70 | 387,11k | - |
| 2025-12-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | 8,55k | 0,00 | Derivative Exercise and Retained Stock | - | 101,93k | 9,15% |
| 2025-12-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | -3,95k | 2,77k | Derivative Exercise and Sale | 0,70 | 101,93k | - |
| 2025-12-01 | Mr. Matthew B. FergusonCFO | 10,00k | 6,61k | Achat | 0,65 - 0,67 | 379,07k | 2,71% |
| 2025-12-01 | Mr. Guido Julius NeelsIndependent Director | 6,25k | 0,00 | Derivative Exercise and Retained Stock | - | 68,75k | 10,00% |
| 2025-11-24 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 5,00k | 3,00k | Achat | 0,60 | 358,79k | 1,41% |
| 2025-11-17 | Mr. David ColpmanIndependent Director | 15,50k | 11,47k | Achat | 0,74 | 18,60k | 500,32% |
| 2025-11-13 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 13,50k | 10,11k | Achat | 0,74 - 0,76 | 353,79k | 3,97% |
| 2025-09-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | 8,55k | 0,00 | Derivative Exercise and Retained Stock | - | 93,39k | 10,08% |
| 2025-09-10 | Dr. Michelle LeRoux WilliamsChief Scientific Officer | -3,95k | 5,37k | Derivative Exercise and Sale | 1,36 | 93,39k | - |
| 2025-09-10 | Mr. Matthew B. FergusonCFO | 18,65k | 0,00 | Derivative Exercise and Retained Stock | - | 369,07k | 5,32% |
| 2025-09-10 | Mr. Matthew B. FergusonCFO | -10,35k | 14,07k | Derivative Exercise and Sale | 1,36 | 369,07k | - |
| 2025-09-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 17,42k | 0,00 | Derivative Exercise and Retained Stock | - | 338,59k | 5,42% |
| 2025-09-10 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | -9,66k | 13,14k | Derivative Exercise and Sale | 1,36 | 338,59k | - |
| 2025-06-21 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | 14,45k | 0,00 | Derivative Exercise and Retained Stock | - | 321,17k | 4,71% |
| 2025-06-21 | Dr. C. Randal MillsCo-Founder, President, CEO & Director | -8,02k | 14,51k | Derivative Exercise and Sale | 1,81 | 321,17k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
